Keyphrases
Long-term Treatment
100%
Insulin Resistance
100%
Placebo-controlled Trial
100%
Metformin
100%
Placebo
62%
Adolescents with Obesity
62%
Body Mass Index
50%
Obesity Resistance
50%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
37%
Body Fat Percentage
25%
Hemoglobin A1c (HbA1c)
25%
Lifestyle Intervention
25%
No Significant Difference
12%
Intervention Therapy
12%
Randomized Placebo-controlled Trial
12%
Twice Daily
12%
Fat Mass
12%
Body Composition
12%
Tolerability
12%
Long-term Efficacy
12%
Double-blind Trial
12%
Median Body
12%
Serious Adverse Events
12%
Physical Training
12%
Long-term Safety
12%
Additional Therapy
12%
Metformin Therapy
12%
Fat-free Mass
12%
Medicine and Dentistry
Insulin Resistance
100%
Glycon
100%
Adolescence
100%
Placebo
100%
Body Mass Index
44%
Homeostatic Model Assessment
33%
Hemoglobin A1c
22%
Lifestyle Intervention
22%
Adverse Event
11%
Body Fat Percentage
11%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Metformin
100%
Insulin Resistance
100%
Hemoglobin A1c
22%
Tolerability
11%
Adverse Event
11%
Immunology and Microbiology
Adolescence
100%
Insulin Resistance
100%
Body Mass
44%
Homeostasis
33%
Fat Free Mass
11%
Body Composition
11%
Fat Mass
11%
Body Fat
11%